AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

CVS GROUP PLC

Business and Financial Review Jul 25, 2016

7590_rns_2016-07-25_44658bfe-cc12-448c-9014-1419c54d51ca.html

Business and Financial Review

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0562F

CVS Group plc

25 July 2016

25 July 2016

CVS Group plc ("CVS" or the "Group")

Trading Update

CVS, the UK's leading provider of integrated veterinary services, is pleased to provide the following trading update in respect of the financial year ended 30 June 2016. All comparative data relates to the year ended 30 June 2015. The Group expects to announce its full year results on Friday 23 September 2016.

Revenue and adjusted EBITDA for the recently ended financial year are expected to be modestly ahead of market expectations.

Group revenue for the year showed total like-for-like growth of 4.8% up from a more customary 3.0% in the first half, reflecting the strong organic growth in our practice revenues during the second half of the year.

Membership of our Healthy Pet Club loyalty schemes grew by 40,000 (19%), from 213,000 pets at the start of the year to 253,000 at the year end. These schemes contributed 16.3% of the like-for-like revenue from practices (2015: 13.5%). 

The year to 30 June 2016 was a record for the Group in terms of the number of acquisitions. 67 surgeries were acquired as well as three crematoria, the Vetshare buying group and the VETisco instrumentation business. A total of £63.7m (including debt acquired) was paid for the acquisitions in the year.

25 surgeries and one crematorium were acquired in the second half of the year:

Name No. of sites Main locations Business
Practice Division
Dart Vale Veterinary Group 6 Dartmouth Small & large animal
Burghfield & Goring Veterinary Group 2 Burghfield, Goring Small animal
Clifton Villa Veterinary Services 5 Newquay, Truro, Cambourne Small & large animal
Valley Equine Hospital 1 Lambourne Equine
Fern Cottage veterinary Surgery 1 Sittingbourne Small animal
Claremont Veterinary Group 2 Bexhill Small animal
Lamorna House Veterinary Centre 1 Cambourne Small animal
Cromlyn House Veterinary Hospital 2 Hillsborough Northern Ireland Small animal
Roebuck Veterinary Group 2 Stevenage Small animal
Seymour Vets 2 Totnes Small animal, large animal & equine
Putlands Veterinary Surgery 1 Paddock Wood Small & large animal
Practice Division total 25
Crematoria Division
Greenacres Crematorium 1 Scunthorpe Crematoria

Of particular note in the second half were the acquisitions of Valley Equine Hospital and Cromlyn House Veterinary Group. Valley Equine is a significant addition to our Equine business in the Thames Valley and complements our existing Scott Dunns business based near Wokingham. Cromlyn House Veterinary Group is our first acquisition in Northern Ireland and we hope to make further acquisitions in Northern Ireland in the future.

We continue to see a significant number of acquisition opportunities and are able to focus on those that offer the best potential for the Group.

The growth of the Practice Division has necessitated the further development of the management structure in order to enhance the support of the practices and maximise their potential.  This will lead to some additional fixed costs although in the medium term these will be offset by the available margin opportunity and will better support the further expansion of the Practice Division.

The Group now operates a total of 360 veterinary surgeries across the UK, an on-line dispensary, four diagnostic laboratories and seven pet crematoria.

The Board anticipates further like-for-like growth although this is likely to moderate to more normal levels following the unusually high growth seen over the last six months. In addition, the full year impact of the acquisitions made during the year ended 30 June 2016 will add significantly to the profitability of the Group. Further acquisitions and general progress across all of the Group's divisions are expected.

This announcement contains inside information.

For further enquiries please contact:

CVS Group plc

Simon Innes, Chief Executive

Nick Perrin, Finance Director
Tel: 01379 644 288
N+1 Singer (Nominated Adviser & Broker)

Aubrey Powell

Liz Yong
Tel: 020 7496 3000

This information is provided by RNS

The company news service from the London Stock Exchange

END

TSTMMGZNNFFGVZG

Talk to a Data Expert

Have a question? We'll get back to you promptly.